Target intelligence / Profile preview

Matrix metalloproteinase 15 (MMP15)

Target
MMP15
Molecular classification
Enzyme, Protease, Metalloprotease, Matrix metalloproteinase
01

Overview

Matrix metalloproteinase 15 (MMP15), also known as membrane-type 2 matrix metalloproteinase (MT2-MMP), is a membrane-bound zinc-dependent endopeptidase that plays a critical role in extracellular matrix (ECM) remodeling (UniProt: P51511). Unlike soluble MMPs, MMP15 is anchored to the cell membrane via a hydrophobic transmembrane domain, allowing localized proteolytic activity at the cell-matrix interface. It degrades key ECM components such as fibronectin, tenascin, and laminin, and acts as an activator of other metalloproteinases like pro-MMP2.

In pathological contexts, MMP15 is frequently upregulated in various malignancies, including lung, colon, and ovarian cancers, where it facilitates tumor cell invasion, metastasis, and tumor-induced angiogenesis. Historically, therapeutic targeting of MMPs relied on broad-spectrum small-molecule inhibitors like Marimastat and Batimastat; however, these failed in clinical trials due to severe dose-limiting musculoskeletal toxicity and lack of selectivity. Current drug discovery efforts focus on developing highly selective monoclonal antibodies or small molecules that target the unique allosteric sites or the hemopexin domain of MMP15 to minimize off-target effects.

Other names
Membrane-type matrix metalloproteinase 2MT-MMP 2MT2-MMPMMP-15Matrix metalloproteinase-15
02

Mechanism of action

Inhibition of enzymatic activity by chelating the active-site zinc ion or blocking the substrate-binding pocket.

03

Biological functions

Extracellular matrix degradationProteolysisCell migrationAngiogenesisTissue remodeling
04

Disease associations

CancerMetastasisInflammation
05

Safety considerations

Musculoskeletal syndrome (MSS) associated with broad-spectrum MMP inhibitionOff-target toxicity due to high structural homology among MMP family members
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

MMP15 expression levelTumor tissue MMP15 immunohistochemistry

Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.

Beyond the preview

Go deeper on Matrix metalloproteinase 15 (MMP15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matrix metalloproteinase 15 (MMP15).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call